1-propyl-2-methyl-3-hydroxypyrid-4-one has been researched along with oxyquinoline in 1 studies
Studies (1-propyl-2-methyl-3-hydroxypyrid-4-one) | Trials (1-propyl-2-methyl-3-hydroxypyrid-4-one) | Recent Studies (post-2010) (1-propyl-2-methyl-3-hydroxypyrid-4-one) | Studies (oxyquinoline) | Trials (oxyquinoline) | Recent Studies (post-2010) (oxyquinoline) |
---|---|---|---|---|---|
8 | 0 | 0 | 1,623 | 28 | 363 |
Protein | Taxonomy | 1-propyl-2-methyl-3-hydroxypyrid-4-one (IC50) | oxyquinoline (IC50) |
---|---|---|---|
Botulinum neurotoxin type A | Clostridium botulinum | 3.9 | |
Catechol O-methyltransferase | Homo sapiens (human) | 2.3736 | |
Methionine aminopeptidase 2 | Homo sapiens (human) | 2.9667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G | 1 |
1 other study(ies) available for 1-propyl-2-methyl-3-hydroxypyrid-4-one and oxyquinoline
Article | Year |
---|---|
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship | 1993 |